US EditionPublished • loading... • Updated
Abx Expands Radiopharma Production in Radeberg
Summary by Oiger
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Saxony is shooting 6.6 million euros in order to eliminate the legacy of the former glassworks before Radeberg, 14 January 2026. In order for "ABX advanced biochemical compounds" to be able to expand its production of ingredients for cancer diagnostics and therapy in Radeberg, the Free State of Saxony is shooting around 6.6 million euros to the Radiopharma company. Today, the Saxon Environment Minister Georg-Ludwig von Breitenbuch (CDU) and the …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
